Teva to Advance Its Anti-IL-15 Antibody, Designed for Quarterly Dosing, Into Phase 2b Development in Vitiligo, Following Encouraging Phase 1b Results

Teva-discovered TEV-’408 targets IL-15, a key driver of vitiligo biology TEV-’408 showed improvement in skin pigmentation and was well-tolerated with no safety signals observed to dateNearly 75% of pa ...

Cyprus Airways Strengthens Direct Digital Sales Channel with PROS airTRFX

Cyprus Airways implements PROS airTRFX to strengthen its direct digital storefront and support direct digital sales.

Cuprum Metals raises $19.4M Series A to accelerate Copper Extraction Technology

Cuprum Metals Inc., a Delaware-based technology company, today announced the close of a US$19.4M Series A funding round led by the Lundin Family Office, and supported by Woodline Partners and BHP ...
The Independent

Why losing weight isn't just about counting calories — and what to do about it

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...